Abstract
Objective:
Adjuvantation of an H5N1 split-virion influenza vaccine with AS03(A) substantially reduces the antigen dose required to produce a putatively protective humoral response and promotes cross-clade neutralizing responses. We determined the effect of adjuvantation on antibody persistence and B- and T-cell-mediated immune responses.
Methods:
Two vaccinations with a split-virion A/Vietnam/1194/2004 (H5N1, clade 1) vaccine containing 3.75-30 μg hemagglutinin and formulated with or without adjuvant were administered to groups of 50 volunteers aged 18-60 years.
Results:
Adjuvantation of the vaccine led to better persistence of neutralizing and hemagglutination-inhibiting antibodies and higher frequencies of antigen-specific memory B cells. Cross-reactive and polyfunctional H5N1-specific CD4 T cells were detected at baseline and were amplified by vaccination. Expansion of CD4 T cells was enhanced by adjuvantation.
Conclusion:
Formulation of the H5N1 vaccine with AS03(A) enhances antibody persistence and induces stronger T- and B-cell responses. The cross-clade T-cell immunity indicates that the adjuvanted vaccine primes individuals to respond to either infection and/or subsequent vaccination with strains drifted from the primary vaccine strain.
Publication types
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adjuvants, Immunologic* / administration & dosage
-
Adolescent
-
Adult
-
Amino Acid Sequence
-
Antibodies, Neutralizing / blood
-
Antibodies, Neutralizing / immunology
-
Antibodies, Viral / blood
-
Antibodies, Viral / immunology
-
B-Lymphocytes / immunology
-
B-Lymphocytes / metabolism
-
CD4-Positive T-Lymphocytes / immunology
-
CD4-Positive T-Lymphocytes / metabolism
-
Cross Reactions / immunology
-
Disease Outbreaks / prevention & control*
-
Female
-
Hemagglutinins / blood
-
Hemagglutinins / immunology
-
Humans
-
Immunity, Cellular*
-
Immunity, Humoral
-
Immunologic Memory
-
Influenza A Virus, H5N1 Subtype* / chemistry
-
Influenza A Virus, H5N1 Subtype* / immunology
-
Influenza Vaccines / administration & dosage*
-
Influenza Vaccines / blood
-
Influenza Vaccines / chemistry
-
Influenza Vaccines / immunology
-
Influenza, Human* / blood
-
Influenza, Human* / immunology
-
Influenza, Human* / prevention & control
-
Male
-
Middle Aged
-
Molecular Sequence Data
-
Vaccination*
-
Vaccines, Inactivated / administration & dosage*
-
Vaccines, Inactivated / blood
-
Vaccines, Inactivated / chemistry
-
Vaccines, Inactivated / immunology
Substances
-
Adjuvants, Immunologic
-
Antibodies, Neutralizing
-
Antibodies, Viral
-
Hemagglutinins
-
Influenza Vaccines
-
Vaccines, Inactivated